On 9 November 2026, Lumos announced that WellStreet Urgent Care will expand adoption of its FebriDx test across its network, with testing rolling out to an additional 97 locations. The network represents more than one million acute respiratory presentations a year, and full coverage …
On 9 November 2026, LTR Pharma announced the Indian Patent Office formally granted Patent No. 605429, which covers defined formulation characteristics of its intranasal technology. The company said the patent supports its SPONTAN and ROXUS products, with protection extending to May 2041, subject to …
Life360’sQuarterly Reporton Form 10-Q for the quarter ended 30 September 2026 showed totalRevenueof $174.1 million, up from $124.5 million a year earlier.Advertisingrevenue rose to $25.4 million from $7.3 million, andNet Incomewas $22.5 million compared with $9.8 million. Subscription revenue reached $124.2 million for the …
Bio-Gene’sQuarterly Reportand Appendix 4C, dated 30 October 2026, said documentation was under way for the first commercialSupplyof Qcide to Japan. Draft OECD toxicity study reports are under review, and tick efficacy data for its Flavocide product was published in a peer-reviewedJournalafter the quarter. The …
Life360 reported total revenue of $174.1 million for the three months ended 30 September 2026, compared with $124.5 million a year earlier. For the nine months, total revenue reached $476.2 million, up from $343.5 million. Subscription revenue rose to $124.2 million from $96.3 million …
archTIS said it was awarded a contract by a NASDAQ-listed, US-headquartered satellite communications and defence technology company. The total contract value is approximately A$217,000, with A$115,000 for Spirion Sensitive Data Manager and archTIS Trusted Data Integration software licences, and A$102,000 for support and customer …
On 4 November 2026, Axtec’s board said it had proposed appointing Andy Taylor as managing director and chief executive. Mr Taylor’s appointment is subject to completing his cornerstoneInvestmentin a $1 millionPlacementand to finalising terms. The company described him as a fintech founder with more …
The company said documentation and product development activities are under way to support the first commercial supply of its Qcide product to Japan. Bio-Gene’s managing director and chief executive attended major meetings in Japan and the United States during the quarter. The company also …
In its FY26 result, released on 19 August 2026, Cosol reported underlying EBITDA of just under $10 million for the full year, with second-half EBITDA of $6.3 million compared with $3.4 million in the first half. The company said operating margins improved to 31.2% …
DXN said it entered a binding contract valued at approximately A$4.8 million, or about US$3.4 million, with a global internet company. The work covers the design,Supplyand commissioning of a modular cable landing station solution, to be deployed at a Pacific region site under US …